Comparative Tolerability Profiles of the Newer versus Older Antidepressants

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Drug Safety

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00002018-199410010-00003PMID 8136085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review of Fluvoxamine Safety Database

  2012cited by this paper
• Efficacy of Fluvoxamine in Severe Depression

  2012cited by this paper
• Suicide and Antidepressants

  2012cited by this paper
• Pharmacological Differences of Serotonin Reuptake Inhibitors and Possible Clinical Relevance

  2012cited by this paper
• The Safety of Antidepressants

  2012cited by this paper
• Comparative Efficacy of Antidepressants

  2012cited by this paper
• Safety of moclobemide taken in overdose for attempted suicide

  2005cited by this paper
• Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine

  2005cited by this paper
• Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment

  2004cited by this paper
• Moclobemide, a new reversible MAO inhibitor — interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients

  2004cited by this paper
• Fluvoxamine-tricyclic antidepressant interaction

  2004cited by this paper
• Tyramine infusions and selective monoamine oxidase inhibitor treatment

  2004cited by this paper
• Alcohol and bupropion pharmacokinetics in healthy male volunteers

  2004cited by this paper
• The effect of bupropion, a new antidepressant drug, and alcohol and their interaction in man

  2004cited by this paper
• The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple doses

  2004cited by this paper
• Tyramine pressor sensitivity changes during deprenyl treatment

  2004cited by this paper
• Paroxetine and extrapyramidal reactions

  1993cited by this paper
• The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered.

  1993cited by this paper
• Hyponatraemia associated with paroxetine.

  1993cited by this paper
• A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder.

  1993cited by this paper
• A double‐blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients

  1993cited by this paper
• Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.

  1993cited by this paper
• Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

  1993cited by this paper
• A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia.

  1993cited by this paper
• Sexual dysfunction during antidepressant treatment.

  1993cited by this paper
• Clinical Pharmacokinetics of Selective Serotonin Reuptake Inhibitors

  1993cited by this paper
• Clinical pharmacokinetics of selective serotonin reuptake inhibitors.

  1993cited by this paper
• A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder

  1993cited by this paper
• Effects of fluvoxamine, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

  1993cited by this paper
• Fluoxetine efficacy in social phobia.

  1993cited by this paper
• The central nervous system serotonin syndrome

  1993cited by this paper
• Obsessive compulsive disorder in children and adolescents: issues in management.

  1993cited by this paper
• Clinical, endocrine and neurochemical effects of moclobemide in depressed patients

  1993cited by this paper
• Spontaneous hypertensive reactions with monoamine oxidase inhibitors.

  1993cited by this paper
• Seizures associated with antidepressants: a review.

  1993cited by this paper
• Serotonin syndrome caused by a moclobemide-clomipramine interaction.

  1993cited by this paper
• Pharmacokinetics of psychotropic drugs in special populations.

  1993cited by this paper
• Increase of Parkinson disability after fluoxetine medication.

  1993cited by this paper
• Tricyclic Antidepressants in Red Cells and Plasma: Correlation with Impaired Intraventricular Conduction in Acute Overdose

  1993cited by this paper
• The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

  1992cited by this paper
• The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.

  1992cited by this paper
• The effect of paroxetine on anxiety and agitation associated with depression.

  1992cited by this paper
• Paroxetine versus placebo: a double-blind comparison in depressed patients.

  1992cited by this paper
• Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

  1992cited by this paper
• Sertraline in the Prevention of Depression

  1992cited by this paper
• Antidepressant medications and the relative risk of suicide attempt and suicide.

  1992cited by this paper
• Adverse cutaneous reactions associated with fluoxetine strategy for reintroduction of this drug in selected patients.

  1992cited by this paper
• Psychotropic Drugs and Injuries Among the Elderly: A Review

  1992cited by this paper
• Acute Administration of Fluoxetine and the Duration of Electrically Induced Seizures.

  1992cited by this paper
• Fluoxetine: no association with suicidality in obsessive-compulsive disorder.

  1992cited by this paper
• Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase‐A inhibitor, and oral tyramine in healthy subjects

  1992cited by this paper
• Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.

  1992cited by this paper
• The safety profile of paroxetine.

  1992cited by this paper
• Treatment of fluoxetine-induced anorgasmia with amantadine.

  1992cited by this paper
• Sertraline Does Not Alter Steady‐State Concentrations or Renal Clearance of Lithium in Healthy Volunteers

  1992cited by this paper
• Pharmacokinetics of the selective serotonin reuptake inhibitors.

  1992cited by this paper
• The safety profile of paroxetine.

  1992cited by this paper
• Akathisia, suicidality, and fluoxetine.

  1992cited by this paper
• Treating depression and anxiety in primary care. Closing the gap between knowledge and practice.

  1992cited by this paper
• Is tranylcypromine really metabolized to amphetamine

  1992cited by this paper
• Amenorrhea and galactorrhea associated with fluvoxamine in a loxapine-treated patient.

  1992cited by this paper
• Fluoxetine: Activating and Sedating Effects at Multiple Fixed Doses

  1992cited by this paper
• Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.

  1992cited by this paper
• Is tranylcypromine really metabolized to amphetamine?

  1992cited by this paper
• Pharmacotherapy of Social Phobia

  1992cited by this paper
• Fluoxetine: activating and sedating effects at multiple fixed doses.

  1992cited by this paper
• The Safety of Antidepressants

  1992cited by this paper
• Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice

  1992cited by this paper
• Fluoxetine, akathisia, and suicidality: is there a causal connection?

  1992cited by this paper
• Fluoxetine inhibits desipramine metabolism.

  1992cited by this paper
• Comparison of SPECT applications in neurology and psychiatry.

  1992cited by this paper
• A fluvoxamine-induced frontal lobe syndrome in a patient with comorbid Gilles de la Tourette's syndrome and obsessive compulsive disorder.

  1992cited by this paper
• Idiosyncratic reactions to antidepressants: a review of the possible mechanisms and predisposing factors.

  1992cited by this paper
• Fluoxetine and Suicidal Behaviour

  1992cited by this paper
• Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III)

  1992cited by this paper
• Fluoxetine impairs clearance of alprazolam but not of clonazepam

  1992cited by this paper
• Moclobemide Versus Clomipramine in Endogenous Depression

  1992cited by this paper
• Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers

  1992cited by this paper
• Service utilization and social morbidity associated with depressive symptoms in the community.

  1992cited by this paper
• Suicidality and fluoxetine: is there a relationship?

  1991cited by this paper
• A Review of Fluvoxamine and its Uses in Depression

  1991cited by this paper
• Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients.

  1991cited by this paper
• Fluoxetine and parkinsonism in patients taking carbamazepine.

  1991cited by this paper
• Elevation of plasma concentrations of haloperidol after the addition of fluoxetine.

  1991cited by this paper
• Clinical pharmacokinetics of tricyclic antidepressant overdose.

  1991cited by this paper
• Tricyclics and heart failure.

  1991cited by this paper
• Recent fluoxetine treatment and complications of tricyclic therapy.

  1991cited by this paper
• Painful ejaculation associated with antidepressants in four patients.

  1991cited by this paper
• Is doxepin a safer tricyclic for the heart?

  1991cited by this paper
• Cardiovascular effects of bupropion in depressed patients with heart disease.

  1991cited by this paper
• Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness.

  1991cited by this paper
• Recent fluoxetine treatment and complications of tricyclic therapy.

  1991cited by this paper
• Fluoxetine‐Induced Tricyclic Toxicity: Extent and Duration

  1991cited by this paper
• A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

  1991cited by this paper
• The serotonin syndrome.

  1991cited by this paper
• Double-blind comparison of bupropion and fluoxetine in depressed outpatients.

  1991cited by this paper
• The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction.

  1991cited by this paper
• Management of hypertensive crises.

  1991cited by this paper
• Menstrual irregularities associated with bupropion treatment.

  1991cited by this paper
• Comorbidity and medical complications of bulimia nervosa.

  1991cited by this paper

• The treatment of behavioural and psychological symptoms in dementia: pragmatic recommendations

  2024cites this paper
• Amitriptyline revitalizes ICB response via dually inhibiting Kyn/Indole and 5-HT pathways of tryptophan metabolism in ovarian cancer

  2024cites this paper
• Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature

  2021cites this paper
• A comparative study to assess the effect of escitalopram and amitriptyline on psychomotor functions in patients of depression

  2020cites this paper
• The Use of Antidepressants in Patients with Heart Failure

  2019cites this paper
• Treatment of Depression in Patients with Concomitant Cardiac Disease.

  2016cites this paper
• Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network

  2015cites this paper
• Older adults recently started on psychotropic medication: where are the symptoms?

  2015cites this paper
• Letters to the editor.

  2014cites this paper
• Part I. Geriatric pharmacology for the dermatologist

  2013cites this paper
• Antidepressant overdose-induced seizures.

  2013cites this paper
• Antidepresan ilaçların gastrik ülser üzerine etkileri

  2013cites this paper
• Supplement to: Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

  2013cites this paper
• Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

  2013cites this paper
• An analysis of the effects of three commonly prescribed antidepressant agents on memory function

  2013cites this paper
• Geriatric dermatology: Part I. Geriatric pharmacology for the dermatologist.

  2013cites this paper
• An analysis of the effects of three commonly prescribed antidepressant agents on psychomotor function

  2013cites this paper
• Impact of antidepressant drug clomipramine on hepatorenal functions, lipid peroxidation, micronucleus frequencies and DNA damage using an alkaline comet assay

  2013cites this paper
• Antidepresan ilaçlarin gastrik ülser üzerine etkileri The effects of antidepressants on gastric ulcer

  2013cites this paper
• FRECUENCIA DE ANSIEDAD Y DEPRESIÓN EN PACIENTES ASA I - II SOMETIDOS A CIRUGIA, EN EL HG1 DE QUITO EN EL PERÍODO DE FEBRERO A ABRIL DEL 2010

  2012cites this paper
• Antidepressant overdose-induced seizures.

  2011cites this paper
• Modern chromatographic and electrophoretic measurements of antidepressants and their metabolites in biofluids.

  2011cites this paper
• Antidepressants Reverse Short-Photoperiod-Induced, Forced Swim Test Depression-Like Behavior in the Diurnal Fat Sand Rat: Further Support for the Utilization of Diurnal Rodents for Modeling Affective Disorders

  2011cites this paper
• Anti-depressant drug prescription pattern for depression at a tertiary health care center of Northern India

  2010cites this paper
• Clomipramine Treatment and Repeated Restraint Stress Alter Parameters of Oxidative Stress in Brain Regions of Male Rats

  2010cites this paper
• Role of α-2 adrenergic receptors in anti-ulcer effect mechanism of estrogen and luteinising hormone on rats

  2009cites this paper
• Protective Effect of Mirtazapine on Indomethacin-Induced Ulcer in Rats and Its Relationship with Oxidant and Antioxidant Parameters

  2009cites this paper
• Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder

  2009cites this paper
• Drug-Induced Urinary Retention

  2008cites this paper
• Chapter 7 Antidepressants and antipsychotics

  2008cites this paper
• Serotonin Reuptake Inhibitors and Other Atypical Antidepressants

  2007cites this paper
• Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder.

  2007cites this paper
• Tricyclic antidepressant-induced acute urine retention in a young woman with postpartum depression--case report.

  2007cites this paper
• Retrospective utilization patterns of antidepressant medications

  2007cites this paper
• Use of Psychotropic Medications in Geriatric Pain Management

  2006cites this paper
• Urinary obstruction with citalopram and aripiprazole combination in an elderly patient.

  2006cites this paper
• Adjunctive pharmacological management of persistent, nonmalignant pain in older individuals

  2006cites this paper
• Suivi toxicocinétique de la viloxazine (forme à libération prolongée) et du citalopram : étude d'une tentative de suicide

  2006cites this paper
• The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression

  2004cites this paper
• Does oxidative stress contribute in tricyclic antidepressants-induced cardiotoxicity?

  2004cites this paper
• Access to drug therapy and substitution between alternative antidepressants following an expansion of the California Medicaid formulary.

  2003cites this paper
• Intoxicaciones del sistema nervioso central

  2003cites this paper
• Regulation by clozapine of calcium handling by rat submandibular acinar cells.

  2003cites this paper
• Successful treatment of reboxetine-induced urinary hesitancy with tamsulosin.

  2002cites this paper
• Six-year perspectives on the safety and tolerability of nefazodone.

  2002cites this paper
• Clinical use of quetiapine in disease states other than schizophrenia.

  2002cites this paper
• The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.

  2002cites this paper
• Drug Therapy for Depression in Japan

  2002cites this paper
• and Safety in Chronic Major Depression.

  2002cites this paper
• Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

  2001cites this paper
• ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.

  2001cites this paper
• Neurotropic and psychotropic drugs in dermatology.

  2001cites this paper
• Adjunctive Agents in the Management of Chronic Pain

  2001cites this paper
• Effects of outreach strategies on quality of pharmacotherapy

  2001cites this paper
• Fluoxetine and Fluvoxamine Combined with Individual Cognitive-Behaviour Therapy in Binge Eating Disorder: A One-Year Follow-Up Study

  2001cites this paper
• Center for Policy Research Working Paper No . 26 ANTIDEPRESSANT TREATMENT FOR DEPRESSION : TOTAL CHARGES AND THERAPY DURATION

  2000cites this paper
• Cost‐effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double‐blind clinical trial

  2000cites this paper
• Fluoxetine : A review of its use in anxiety disorders and mixed anxiety and depression

  2000cites this paper
• Cognitive and Psychomotor Effects of Antidepressants with Emphasis on Selective Serotonin Reuptake Inhibitors and the Depressed Elderly Patient

  2000cites this paper
• Racial variation in antidepressant treatment in a Medicaid population.

  2000cites this paper
• The Need for an Iterative Process for Assessing Economic Outcomes Associated with SSRIs

  2000cites this paper
• Antidepressant treatment for depression: total charges and therapy duration*

  2000cites this paper
• Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects.

  2000cites this paper
• Effect of Antidepressant Choice on the Incidence and Economic Intensity of Hospitalization Among Depressed Individuals

  2000cites this paper
• Depression in Palliative Care Patients

  2000cites this paper
• Comparing the efficacy and safety of fluoxetine and venlafaxine in outpatient depression.

  1999cites this paper
• Metabolism of Tricyclic Antidepressants

  1999influential citation
• Weight gain and antipsychotic medications.

  1999cites this paper
• Drug-Induced Cognitive Impairment in the Elderly

  1999cites this paper
• Access to Treatment for Depression in a Medicaid Population

  1999cites this paper
• Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI.

  1999cites this paper
• Selective contracting and patient outcomes: a case study of formulary restrictions for selective serotonin reuptake inhibitor antidepressants.

  1999cites this paper
• Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.

  1999cites this paper
• [Depression in old age].

  1999cites this paper
• Ileus as a possible result of bupropion in an elderly woman.

  1999cites this paper
• Risperidone treatment of tardive dyskinesia and dystonia.

  1999cites this paper
• The role of SSRI antidepressants for treating depressed patients in the California Medicaid (Medi-Cal) program.

  1999cites this paper
• Relationship between antidepressant treatment and suicide.

  1999cites this paper
• Methamphetamine-associated obsessional symptoms and effective risperidone treatment: a case report.

  1999cites this paper
• Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studies.

  1999cites this paper
• Information needs for medication coverage decisions in a state Medicaid program.

  1999cites this paper
• Behavioural toxicity of antianxiety and antidepressant agents

  1999cites this paper
• Assessment of Adverse Drug Reactions in Psychiatric Inpatients with the AMSP Drug Safety Program: Methods and First Results for Tricyclic Antidepressants and SSRI

  1999cites this paper
• Undesirable Blood Pressure Changes Under Naturalistic Treatment with Moclobemide, a Reversible MAO-A Inhibitor - Results of the Drug Utilization Observation Studies

  1999cites this paper
• Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis.

  1998cites this paper
• Cost-effectiveness of antidepressant medications.

  1998cites this paper
• Differential pharmacology of newer antidepressants.

  1998cites this paper
• Care of depression in the elderly: comparative pharmacokinetics of SSRIs

  1998cites this paper
• Fluoxetine. A pharmacoeconomic review of its use in depression.

  1998cites this paper
• [Depression and cancer: therapeutic aspects].

  1998cites this paper
• The journal of mental health policy and economics

  1998cites this paper
• Bupropion sustained release and smoking cessation.

  1998cites this paper
• Fluoxetineic Review of its Use in Depression

  1998cites this paper
• Bodyweight Gain Induced by Psychotropic Drugs

  1998cites this paper
• SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

  1997cites this paper
• Side Effect Profile and Safety of Antidepressants in Light of New Therapeutic Indications

  1997cites this paper
• Pharmacology of antidepressants.

  1997cites this paper
• Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor.

  1997cites this paper
• Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.

  1997cites this paper
• Management of patients with depression associated with anxiety symptoms.

  1997cites this paper